Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

On July 4, President Donald Trump signed into law “The One Big Beautiful Bill Act,” which is expected to deal a massive blow to Medicaid coverage and leave millions without insurance by instituting a work requirement for beneficiaries.

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

A report from the nonpartisan Congressional Budget Office said that proposed cuts at NIH could lead to a decrease in the number of new drugs that come to market in the next three decades.

July 25, 2025

Vol.51 No.29

By Paul Goldberg

Podcast The Directors

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.

July 18, 2025

Vol.51 No.28

By Paul Goldberg and Katie Goldberg

Cancer Policy

NIH says it’s moving away from animal-based models

NIH has announced that it will no longer be issuing Notices of Funding Opportunities exclusively supporting animal models.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

In the Archives

Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology

The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

Over 20 scientists whose grants have been canceled by the Trump administration presented posters on their now-terminated work at “The Things We’ll Never Know: A Science Fair of Canceled Grants.”

July 11, 2025

Vol.51 No.27

By Jacquelyn Cobb

Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

YOU MAY BE INTERESTED IN

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

NIH says it’s moving away from animal-based models

Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology

House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

Renew today!

Subscriber content

Never miss an issue!

Login

Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

YOU MAY BE INTERESTED IN

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentumAs oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

NIH says it’s moving away from animal-based models

Rick and Mary Pazdur on facing “the other side of the stethoscope”A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology

House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

Never miss an issue!

Login

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology